These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 33691168)

  • 1. Identification of 2-fluoro-8-methyl-11-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)-5H-dibenzo[b,e][1,4]diazepine with clozapine-like mixed activities at muscarinic acetylcholine, dopamine, and serotonin receptors.
    Watanabe H; Ishida K; Yamamoto M; Nakako T; Horiguchi M; Isobe Y
    Bioorg Med Chem Lett; 2021 May; 40():127911. PubMed ID: 33691168
    [No Abstract]   [Full Text] [Related]  

  • 2. Binding of 5H-dibenzo[b,e][1,4]diazepine and chiral 5H-dibenzo[a,d]cycloheptene analogues of clozapine to dopamine and serotonin receptors.
    Phillips ST; de Paulis T; Baron BM; Siegel BW; Seeman P; Van Tol HH; Guan HC; Smith HE
    J Med Chem; 1994 Aug; 37(17):2686-96. PubMed ID: 8064797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and pharmacological evaluation of 11-(1,6-dimethyl-1,2,3,6-tetrahydropyridin-4-yl)-5H-dibenzo[b,e][1,4]diazepines with clozapine-like receptor occupancy at dopamine D
    Watanabe H; Ishida K; Yamamoto M; Horiguchi M; Isobe Y
    Bioorg Med Chem Lett; 2020 Nov; 30(21):127563. PubMed ID: 32976928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azepinoindole derivatives with high affinity for brain dopamine and serotonin receptors.
    Maryanoff BE; McComsey DF; Martin GE; Shank RP
    Bioorg Med Chem Lett; 1998 Apr; 8(8):983-8. PubMed ID: 9871525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of 5H-dibenzo[a,d]cycloheptene and dibenz[b,f]oxepin analogues of clozapine to dopamine and serotonin receptors.
    Phillips ST; de Paulis T; Neergaard JR; Baron BM; Siegel BW; Seeman P; Van Tol HH; Guan HC; Smith HE
    J Med Chem; 1995 Feb; 38(4):708-14. PubMed ID: 7861418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chloro-substituted, sterically hindered 5,11-dicarbo analogues of clozapine as potential chiral antipsychotic agents.
    Davis DA; de Paulis T; Janowsky A; Smith HE
    J Med Chem; 1990 Feb; 33(2):809-14. PubMed ID: 1967652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.
    Seeman P; Tallerico T
    Mol Psychiatry; 1998 Mar; 3(2):123-34. PubMed ID: 9577836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.
    Tauscher J; Hussain T; Agid O; Verhoeff NP; Wilson AA; Houle S; Remington G; Zipursky RB; Kapur S
    Am J Psychiatry; 2004 Sep; 161(9):1620-5. PubMed ID: 15337652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscarinic mechanisms of antipsychotic atypicality.
    Bymaster FP; Felder CC; Tzavara E; Nomikos GG; Calligaro DO; Mckinzie DL
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1125-43. PubMed ID: 14642972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of novel antipsychotic trans-4-(2-(1,2,4,5-tetrahydro-3H-benzo[d]azepin-3-yl)ethyl)cyclohexan-1-amine derivatives targeting dopamine/serotonin receptor subtypes.
    Xu JW; Qi YL; Wu JW; Yuan RX; Chen XW; Li JQ
    Bioorg Med Chem Lett; 2021 Jan; 31():127681. PubMed ID: 33189775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological profile of antipsychotics at monoamine receptors: atypicality beyond 5-HT2A receptor blockade.
    Wood MD; Scott C; Clarke K; Cato KJ; Patel N; Heath J; Worby A; Gordon L; Campbell L; Riley G; Davies CH; Gribble A; Jones DN
    CNS Neurol Disord Drug Targets; 2006 Aug; 5(4):445-52. PubMed ID: 16918396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral pharmacology of olanzapine: a novel antipsychotic drug.
    Moore NA; Leander JD; Benvenga MJ; Gleason SD; Shannon H
    J Clin Psychiatry; 1997; 58 Suppl 10():37-44. PubMed ID: 9265915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism.
    Ichikawa J; Li Z; Dai J; Meltzer HY
    Brain Res; 2002 Nov; 956(2):349-57. PubMed ID: 12445705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences.
    Aringhieri S; Carli M; Kolachalam S; Verdesca V; Cini E; Rossi M; McCormick PJ; Corsini GU; Maggio R; Scarselli M
    Pharmacol Ther; 2018 Dec; 192():20-41. PubMed ID: 29953902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine and serotonin receptors: amino acid sequences, and clinical role in neuroleptic parkinsonism.
    Seeman P; Corbett R; Nam D; Van Tol HH
    Jpn J Pharmacol; 1996 Jul; 71(3):187-204. PubMed ID: 8854201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the effects of receptor-selective ligands in rats discriminating the novel antipsychotic quetiapine.
    Goudie AJ; Smith JA; Millan MJ
    Psychopharmacology (Berl); 2004 Jan; 171(2):212-22. PubMed ID: 14691616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular combination of the dopamine and serotonin scaffolds yield in novel antipsychotic drug candidates - characterization by in vivo experiments.
    Schulze M; Siol O; Robaa D; Mueller FK; Enzensperger C; Fleck C; Lehmann J
    Arzneimittelforschung; 2012 May; 62(5):252-60. PubMed ID: 22488415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioreceptor binding profile of the atypical antipsychotic olanzapine.
    Bymaster FP; Calligaro DO; Falcone JF; Marsh RD; Moore NA; Tye NC; Seeman P; Wong DT
    Neuropsychopharmacology; 1996 Feb; 14(2):87-96. PubMed ID: 8822531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo pharmacological profile of 5-[2-[4-(6-fluoro-1H-indole-3-yl)piperidin-1-yl]ethyl]-4-(4-fluorophenyl)thiazole-2-carboxylic acid amide (NRA0562), a novel and putative atypical antipsychotic.
    Funakoshi T; Chaki S; Kawashima N; Suzuki Y; Yoshikawa R; Kumagai T; Nakazato A; Kameo K; Goto M; Okuyama S
    Life Sci; 2002 Aug; 71(12):1371-84. PubMed ID: 12127158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of serotonin-dopamine interactions in the action of clozapine.
    Meltzer HY
    Br J Psychiatry Suppl; 1992 May; (17):22-9. PubMed ID: 1358125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.